These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29495562)

  • 1. Necessary, but Not Sufficient. The Benefit Concept in the Project Evaluation of Animal Research in the Context of Directive 2010/63/EU.
    Eggel M; Grimm H
    Animals (Basel); 2018 Feb; 8(3):. PubMed ID: 29495562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Road to Hell Is Paved with Good Intentions: Why Harm-Benefit Analysis and Its Emphasis on Practical Benefit Jeopardizes the Credibility of Research.
    Grimm H; Eggel M; Deplazes-Zemp A; Biller-Andorno N
    Animals (Basel); 2017 Sep; 7(9):. PubMed ID: 28892015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reviewing the Review: A Pilot Study of the Ethical Review Process of Animal Research in Sweden.
    Jörgensen S; Lindsjö J; Weber EM; Röcklinsberg H
    Animals (Basel); 2021 Mar; 11(3):. PubMed ID: 33807898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm-Benefit Analysis May Not Be the Best Approach to Ensure Minimal Harms and Maximal Benefits of Animal Research-Alternatives Should Be Explored.
    Gutfreund Y
    Animals (Basel); 2020 Feb; 10(2):. PubMed ID: 32059540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Navigating Uncertainties: How to Assess Welfare and Harm in Genetically Altered Animals Responsibly-A Practical Guideline.
    Zintzsch A; Noe E; Grimm H
    Animals (Basel); 2020 May; 10(5):. PubMed ID: 32429139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case for integrity: gains from including more than animal welfare in animal ethics committee deliberations.
    Röcklinsberg H; Gamborg C; Gjerris M
    Lab Anim; 2014 Jan; 48(1):61-71. PubMed ID: 24367033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mission impossible accomplished? A European cross-national comparative study on the integration of the harm-benefit analysis into law and policy documents.
    Hajosi D; Grimm H
    PLoS One; 2024; 19(2):e0297375. PubMed ID: 38377057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The upper limits of pain and suffering in animal research.
    Beauchamp TL; Morton DB
    Camb Q Healthc Ethics; 2015 Oct; 24(4):431-47. PubMed ID: 26364778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephalopods in neuroscience: regulations, research and the 3Rs.
    Fiorito G; Affuso A; Anderson DB; Basil J; Bonnaud L; Botta G; Cole A; D'Angelo L; De Girolamo P; Dennison N; Dickel L; Di Cosmo A; Di Cristo C; Gestal C; Fonseca R; Grasso F; Kristiansen T; Kuba M; Maffucci F; Manciocco A; Mark FC; Melillo D; Osorio D; Palumbo A; Perkins K; Ponte G; Raspa M; Shashar N; Smith J; Smith D; Sykes A; Villanueva R; Tublitz N; Zullo L; Andrews P
    Invert Neurosci; 2014 Mar; 14(1):13-36. PubMed ID: 24385049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm-Benefit Analyses Can Be Harmful.
    Niemi SM
    ILAR J; 2021 Sep; 60(3):341-346. PubMed ID: 32785593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidance on determining indispensability and balancing potential benefits of animal experiments with costs to the animals with specific consideration of EU directive 2010/63/EU.
    Lindl T; Gross U; Ruhdel I; von Aulock S; Völkel M
    ALTEX; 2012; 29(2):219-28. PubMed ID: 22562491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the ethical acceptability of animal research.
    Bout HJ; Fentener van Vlissingen JM; Karssing ED
    Lab Anim (NY); 2014 Nov; 43(11):411-4. PubMed ID: 25333594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods].
    Sauer UG; Kolar R; Rusche B
    ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3Rs and animal welfare - conflict or the way forward?
    Rusche B
    ALTEX; 2003; 20(Suppl 1):63-76. PubMed ID: 14671703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluating Benefits in the Moral Justification of Animal Research: A Comment on "Necessary Conditions for Morally Responsible Animal Research".
    Eggel M; Neuhaus CP; Grimm H
    Camb Q Healthc Ethics; 2020 Jan; 29(1):131-143. PubMed ID: 31858941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective harm benefit analysis of pre-clinical animal research for six treatment interventions.
    Pound P; Nicol CJ
    PLoS One; 2018; 13(3):e0193758. PubMed ID: 29590200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harm-benefit analysis - what is the added value? A review of alternative strategies for weighing harms and benefits as part of the assessment of animal research.
    Grimm H; Olsson IAS; Sandøe P
    Lab Anim; 2019 Feb; 53(1):17-27. PubMed ID: 29966482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on the sub-group reports of the EU Technical Expert Working Group on the revision of Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes.
    Combes R; Balls M
    Altern Lab Anim; 2007 Mar; 35(1):155-75. PubMed ID: 17411363
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.